本产品信息由(厦门慧嘉生物科技有限公司)为您提供,内容包括( Raltegravir (potassium salt) (50 mg) -MK 0518; N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-4-pyrimidinecarboxamide, monopotassium salt)的品牌、型号、技术参数、详细介绍等;如果您想了解更多关于( Raltegravir (potassium salt) (50 mg) -MK 0518; N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-4-pyrimidinecarboxamide, monopotassium salt)的信息,请直接联系供应商,给供应商留言。若当前页面内容侵犯到您的权益,请及时告知我们,我们将马上修改或删除。